This site contains promotional content intended for Healthcare Professionals in Ireland and other relevant decision makers | Not a HCP? Visit our Public Site.
Adverse Event reporting can be found at the bottom of the page | Prescribing Information for the relevant medicine can be found adjacent to the below content and/or in the footer below. 

  • Products
  • Therapy Area
  • Resources
  • Events & Webinars
  • Learning Zone
  • Podcasts
Name BayerPRO IRE Above Brand Header

Cardiology Products

About Beyonttra®▼ (acoramidis)
Learn more about Beyonttra® (acoramidis).
PP-BEY-IE-0031-1, November 2025

Oncology Products

About NUBEQA® (darolutamide)
Access key information about NUBEQA® (darolutamide).
PP-NUB-IE-0264-1, December 2025
About Xofigo®▼ (radium-223 dichloride)
Access key information about Xofigo®.
PP-XOF-IE-0127-1, January 2026

Ophthalmology Products

About EYLEA® (aflibercept) 8mg
Discover data and resources about EYLEA 8mg.
PP-EYL_8mg-IE-0150-1, January 2026

Women's Health Products

Jaydess®▼(13.5mg Levonorgestrel)
Discover information about Jaydess's intended use.
PP-JAY-IE-0056-1, January 2026
Qlaira® (Estradiol valerate/dienogest)
Discover more about intended use of Qlaira®
PP-QLA-IE-0001-1, January 2026
Kyleena® (19.5mg Levonorgestrel)
Discover information about Kyleena's intended usage.
PP-KYL-IE-0252-1, January 2026
Mirena® (52mg levonorgestrel) Intrauterine System
Learn more about Mirena®.
PP-MIR-IE-0069-1, January 2026